de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Characterization of the sigma ligand panamesine by immune response during four-weeks treatment in patients with schizophrenia and by sleep-EEG changes in normal controls.

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons80326

Frieboes,  R. M.
Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80453

Murck,  H.
AG Steiger, Axel, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80478

Pollmächer,  T.
Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80541

Steiger,  A.
AG Steiger, Axel, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Frieboes, R. M., Murck, H., Antonijevic, I. A., Kraus, T., Hinze-Selch, D., Pollmächer, T., et al. (1999). Characterization of the sigma ligand panamesine by immune response during four-weeks treatment in patients with schizophrenia and by sleep-EEG changes in normal controls. Psychopharmacology, 141, 107-110.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-A612-A
Abstract
There is no abstract available